PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8850876

PEG--percutaneous endoscopic gastrostomy.

H Kyle
View original source ↗Export metadata ↓

Abstract

Percutaneous Endoscopic Gastrostomy is simply a plastic tube, placed in the stomach and passed through both the wall of the stomach and abdomen with the aid of a gastroscope, therefore avoiding the need for a laparotomy to form a gastrostomy. Egeberg proposed surgical gastrostomy in 1837. This was not carried out successfully until 1876 by Verneuil. The procedure, however, requires laparotomy and anaesthesia with its associated risks. The first gastrostomy without the need for a laparotomy is reported to have been performed in 1979 by Gauderer and Ponsky at Case Western Reserve University School of Medicine, Cleveland, USA. In 1980 they described the technique. Since then a variety of kits with which to perform the procedure have become available. PEG can be used for long term enteral nutrition or as an intermediate stage between Total Parentral Nutrition (TPN) and normal feeding. An important requirement is a successfully accomplished gastroscopy.

Explore related subjects

Enteral NutritionGastrostomyHumansOperating Room NursingJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H Kyle. 1996. PEG--percutaneous endoscopic gastrostomy.. https://pubmed.ncbi.nlm.nih.gov/8850876/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Nutritional modulation of the inflammatory response in inflammatory bowel disease--from the molecular to the integrative to the clinical.

Nutrient deficiencies are common in patients with inflammatory bowel disease (IBD). Both total parenteral and enteral nutrition provide important supportive therapy for IBD patients, but in adults these are not useful for primary therapy. Dietary intervention with omega-3 polyunsaturated fatty acids contained in fish oil may be useful for the care of IBD patients, and recent studies have stressed the role of PPAR on NFkappaB activity on the potential beneficial effect of dietary lipids on intestinal function.

Enteral Nutrition↗
PubMed2007

Enteral water for hypernatremia and intestinal morbidity in infants less than or equal to 1000 g birth weight.

OBJECTIVE: To evaluate the relationship between enteral water infusion for hypernatremia and significant intestinal morbidity in infants or=150 (high sodium control), >or=150 and treated with sterile water (study group). Significant intestinal morbidity was defined as probable or proven necrotizing enterocolitis or spontaneous intestinal perforation. Statistical analysis included Student's t test for continuous variables and chi(2) with Yeats correction for frequency variables. Multivariate logistic regression analysis was then performed to evaluate confounding variables among groups. RESULTS: The incidence of intestinal morbidity was significantly higher in the high sodium-water treated group compared to each of the other groups (13/33 (38%) for high sodium-water versus 16/100 (16%) for high sodium control and 18/188 (10%) for normal sodium control, P<0.01 chi(2)). Logistic regression analysis indicated that enteral water and hydrocortisone were risk factors for significant intestinal morbidity. CONCLUSIONS: Enteral sterile water for hypernatremia appears to be associated with significant intestinal morbidity in infants <or=1000 g. Hydrocortisone is also a risk factor.

Enteral Nutrition↗